Charles River

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions.

CEO

James C. Foster

CEOJames C. Foster

Employees

19,700

Employees19,700

Headquarters

Wilmington, Massachusetts

HeadquartersWilmington, Massachusetts

Founded

1947

Founded1947

Employees

19,700

Employees19,700

CRL Key Statistics

Market cap

8.26B

Market cap8.26B

Price-Earnings ratio

-56.68

Price-Earnings ratio-56.68

Dividend yield

—

Dividend yield—

Average volume

1.73M

Average volume1.73M

High today

$170.89

High today$170.89

Low today

$166.67

Low today$166.67

Open price

$170.86

Open price$170.86

Volume

959.06K

Volume959.06K

52 Week high

$228.88

52 Week high$228.88

52 Week low

$91.86

52 Week low$91.86

Stock Snapshot

With a market cap of 8.26B, Charles River(CRL) trades at $167.56. The stock has a price-to-earnings ratio of -56.68.

During the trading session on 2026-02-26, Charles River(CRL) shares reached a daily high of $170.89 and a low of $166.67. At a current price of $167.56, the stock is +0.5% higher than the low and still -1.9% under the high.

Trading volume for Charles River(CRL) stock has reached 959.06K, versus its average volume of 1.73M.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

CRL News

TipRanks 10h

Charles River: Portfolio Reshaping Improves Margins but Lowers Growth, Supporting Hold Rating

Analyst Kallum Titchmarsh of Morgan Stanley maintained a Hold rating on Charles River Labs, retaining the price target of $185.00. Claim 50% Off TipRanks Premiu...

Benzinga 21h

Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans

Charles River Laboratories (NYSE:CRL) on Wednesday announced significant plans to divest parts of its business. Charles River agreed to divest its CDMO and Cel...

TipRanks 22h

Charles River price target raised to $175 from $170 at UBS

UBS raised the firm’s price target on Charles River (CRL) to $175 from $170 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate...

Analyst ratings

53%

of 19 ratings

Buy

52.6%

Hold

42.1%

Sell

5.3%

More CRL News

TipRanks 23h

Iqvia to acquire certain discovery services assets from Charles River

Iqvia (IQV) announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories (CRL). These assets include...

Simply Wall St 2d

Assessing Charles River Laboratories Valuation After Earnings Beat And 2026 Improvement Guidance

Advertisement Why Charles River Laboratories International (CRL) Is Back on Investor Radar Charles River Laboratories International (CRL) has drawn attention...

TipRanks 6d

Buy Rating on Charles River Labs: Attractive Entry Point as AI Fears Overhang Fundamentals and Multiple Expansion Potential

Analyst Charles Rhyee from TD Cowen maintained a Buy rating on Charles River Labs and decreased the price target to $235.00 from $251.00. Charles Rhyee has giv...

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Nike

PayPal

AMD

Thermo Fisher Scientific

Pfizer

Salesforce

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.